Market Research Assistance

On the Web
Refine Result

By Date

Last Month
Last 3 Months
Last 6 Months
Last Year
Last 2 Years

By Price

< $1000
$1000-$2500
$2501-$4000
$4001-$5500
$5501-$7500
$7501-$9000
>$9000

Multiple Sclerosis Drugs Market Research Reports

Titlepublishedprice

Multiple Sclerosis-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... key objective of the Multiple Sclerosis Report is to understand the market and pipeline status of the drugs around the Multiple Sclerosis to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on d......"
01-Sep-2016$2000

Relapsing Multiple Sclerosis (RMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... ss the globe. A key objective of the Relapsing Multiple Sclerosis (RMS) Report is to understand the market and pipeline status of the drugs around the Relapsing Multiple Sclerosis (RMS) to explore the generic development opportunities, licensing oppo......"
01-Sep-2016$2000

Relapsing Remitting Multiple Sclerosis (RRMS)-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

By Delve Insight
"...... turers across the globe. A key objective of the Relapsing Remitting Multiple Sclerosis (RRMS) Report is to understand the market and pipeline status of the drugs around the Relapsing Remitting Multiple Sclerosis (RRMS) to explore the generic developm......"
01-Sep-2016$2000

Global and Chinese Interferon Beta Industry, 2016 Market Research Report

By Prof Research
"...... ufacturers and is a valuable source of guidance and direction for companies and individuals interested in the industry.Firstly, the report provides a basic overview of the industry including its definition, applications and manufacturing technology. ......"
06-Aug-2016$2800

Secondary Progressive Multiple Sclerosis (SPMS) - Pipeline Review, H2 2016

By Global Markets Direct
"...... or Secondary Progressive Multiple Sclerosis (SPMS), complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers the descriptive pharmacological action......"
20-Jul-2016$2000

Global Multiple Sclerosis Drugs Market Professional Survey Report 2016

By QYResearch Group
"...... The players list (Partly, Players you are interested in can also be added) Biogen Teva Pharmaceutical Merck KGaA Novartis Bayer Sanofi Acorda Therapeutics Questcor Pharmaceuti......"
04-Jul-2016$3500

Global Multiple Sclerosis Partnering 2010 to 2016

By Current Partnering
"...... g Terms and Agreements since 2010 report provides understanding and access t- partnering deals and agreements entered int- by the world's leading healthcare companies. - Trends in partnering deals - Top deals by value - D......"
01-Jul-2016$1495

Global Multiple Sclerosis Industry 2016 Market Research Report

By QYResearch Group
"...... stry chain structure. The Multiple Sclerosis market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Secondly, development policies ......"
08-Jun-2016$2800

Global Fingolimod Industry 2016 Market Research Report

By QYResearch Group
"...... ture. The Fingolimod market analysis is provided for the international market including development history, competitive landscape analysis, and major regions' development status. Secondly, development policies and plans are discussed ......"
02-Jun-2016$2800

Global Fingolimod Market Professional Survey Report 2016

By QYResearch Group
"...... USA China Europe South America Japan Africa The players list (Partly, Players you are interested in can also be added) Novartis AstraZeneca With no less than......"
01-Jun-2016$3500